Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
10.52
+0.72 (7.35%)
At close: Sep 5, 2025, 4:00 PM
10.37
-0.15 (-1.43%)
After-hours: Sep 5, 2025, 7:46 PM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $915.71 million as of September 5, 2025. Its market cap has increased by 0.25% in one year.
Market Cap
915.71M
Enterprise Value
651.82M
1-Year Change
0.25%
Ranking
Category
Stock Price
$10.52
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $915.71M, an increase of 722.07%. That is a compound annual growth rate of 53.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 915.71M | 38.14% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
| Oct 2, 2020 | 111.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.53B |
| Johnson & Johnson | 429.05B |
| AbbVie | 376.19B |
| UnitedHealth Group | 283.97B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 232.37B |